Low Free Triiodothyronine Levels are Related to Poor Prognosis in Acute Ischemic Stroke

Abstract

Background: Neuroendocrine changes are important processes which accompany critical illness, however, the number of clinical studies concentrating on the role of thyroid gland hormones in stroke pathogenesis is relatively small. The aim of this prospective study was to investigate the relation between free triiodothyronine (fT3) levels and the prognosis of patients with stroke.

Methods: The prospective study included 387 patients with acute (<24 h of symptoms onset) ischemic stroke consecutively admitted to Stroke Units. The subjects with known conditions that could interfere with thyroid gland metabolism were excluded. We analyzed: the routine blood tests, fT3, free thyroxine (fT4), thyroid-stimulating hormone (TSH) levels, unenhanced CT scans, initial clinical status (NIH Stroke Scale, NIHSS), 30- and 360- days outcome (modified Rankin Scale-mRS) and calculated the survival rate.

Results: A higher NIHSS score was in the 1^st fT3 levels tertile, whereas a lower in the 3^rd fT3 levels tertile (p=0.006). The 30- and 360-days mRS scores showed that patients in the lowest fT3 tertile had more severe neurological impairment than those in the highest tertile (p=0.001 and p=0.03, respectively). A 1-year mortality of the patients with the first tertile fT3 levels was significantly higher than that of the patients with the third tertile hormone levels (p=0.008). Additionally, subjects with fT3 level in the lowest tertile demonstrated higher WBC counts and the ventricular system on Computed Tomography of head performed on admission to hospital was statistically more frequent compressed than that in the patients with fT3 level in the highest tertile (p=0.02 and p=0.03, respectively).

Conclusion: In acute stroke patients lower free T3 levels are an important factor related to unfavorable outcome, i. e., severe disability and death.

Key words

triiodothyronine - nonthyroidal illness syndrome - cerebrovascular disease

References

• 1 Alevizaki M, Synetou M, Xynos K. et al . Low triiodothyronine: a strong predictor of outcome in acute stroke patients.  Eur J Clin Invest. 2007;  37 651-657
• 2 Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.  Stroke. 2007;  38 1091-1096
• 3 Bax ND, Lennard MS, Tucker GT. Effect of beta-blockers on thyroid hormone.  Br Med J. 1980;  281 (6250) 1283
• 4 Bonita R, Beaglehole R. Recovery of motor function after stroke.  Stroke. 1988;  19 1497-1500
• 5 Brott T, Adams Jr HP, Olinger CP. et al . Measurement of acute cerebral infarction: a clinical examination scale.  Stroke. 1989;  20 864-870
• 6 Cernak I, Savic VJ, Lazarov A. et al . Neuroendocrine responses following graded traumatic brain injury in male adults.  Brain Inj. 1999;  13 1005-1015
• 7 Chamorro A. Role of inflammation in stroke and atherothrombosis.  Cerebrovasc Dis. 2004;  17 (S 03) 1-5
• 8 Chinga-Alayo E, Villena J, Evans AT. et al . Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit.  Intensive Care Med. 2005;  31 1356-1361
• 9 Chopra IJ. Clinical review 86: Euthyroid sick syndrome: is it a misnomer?.  J Clin Endocrinol Metab. 1997;  82 329-334
• 10 De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome.  J Clin Endocrinol Metab. 1999;  84 151-164
• 11 Fassbender K, Schmidt R, Mössner R. et al . Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome.  Stroke. 1994;  25 1105-1108
• 12 Friberg L, Werner S, Eggertsen G. et al . Rapid Down-regulation of Thyroid Hormones in Acute Myocardial Infarction: Is It Cardioprotective in Patients With Angina?.  Arch Intern Med. 2002;  162 1388-1394
• 13 Grau AJ, Boddy AW, Dukovic DA. et al . Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events.  Stroke. 2004;  35 1147-1152
• 14 Iervasi G, Pingitore A, Landi P. et al . Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease.  Circulation. 2003;  107 708-713
• 15 Iltumur K, Olmez G, Ariturk Z. et al . Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome.  Crit Care. 2005;  9 R416-R424
• 16 Johansson A, Olsson T, Carlberg B. et al . Hypercortisolism after stroke – partly cytokine-mediated?.  J Neurol Sci. 1997;  147 43-47
• 17 Kaplan MM. Clinical perspectives in the diagnosis of thyroid disease.  Clin Chem. 1999;  45 1377-1383
• 18 Karadag F, Ozcan H, Karul AB. et al . Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease.  Respir Med. 2007;  101 1439-1446
• 19 Kazmierski R, Guzik P, Ambrosius W. et al . Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients.  Clin Neurol Neurosurg. 2004;  107 38-43
• 20 Kilinç AS, Düzoylum A, Uncugil CF. et al . Falsely increased free triiodothyronine in sera stored in serum separator tubes.  Clin Chem. 2002;  48 2296-2297
• 21 Koenig RJ. Modeling the nonthyroidal illness syndrome.  Curr Opin Endocrinol Diabetes Obes. 2008;  15 466-469
• 22 Kostopanagiotou G, Kalimeris K, Mourouzis I. et al . Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences.  Endocrine. 2009;  36 198-204
• 23 Nowinski WL, Qian G, Kirgaval Nagaraja BP. et al . Analysis of ischemic stroke MR images by means of brain atlases of anatomy and blood supply territories.  Acad Radiol. 2006;  13 1025-1034
• 24 Nowinski WL, Qian G, Bhanu Prakash KN. et al .Stroke Suite: CAD systems for acute ischemic stroke, hemorrhagic stroke, and stroke in ER. In: Gao X, Muller H, Loomers M, Comley R, Luo S, editors Medical imaging and informatics, Lecture Notes in Computer Science. Berlin/Heidelberg: Springer; 2008: 377-386
• 25 Marklund N, Peltonen M, Nilsson TK. et al . Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke.  J Intern Med. 2004;  256 15-21
• 26 Pingitore A, Landi P, Taddei MC. et al . Triiodothyronine levels for risk stratification of patients with chronic heart failure.  Am J Med. 2005;  118 132-136
• 27 Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?.  N Engl J Med. 1995;  333 1562-1563
• 28 Scoscia E, Baglioni S, Eslami A. et al . Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study.  Eur J Endocrinol. 2004;  151 557-560
• 29 Stockigt J. Assessment of thyroid function: towards an integrated laboratory-clinical approach.  Clin Biochem Rev. 2003;  24 109-122
• 30 Welsh P, Barber M, Langhorne P. et al . Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.  Cerebrovasc Dis. 2009;  27 247-253

Correspondence